Abstract:During 1976, 80 patients with a primary depressive illness were selected from a consecutive series of referrals to the Royal Edinburgh Hospital for a short-term follow-up study. This paper concerns the 12-year longitudinal assessment of the survivors. During the follow-up, mortality risk for the sample was almost doubled. Of the series, 35% had experienced a recurrence within 2 years of the initial interview, and just over 60% within the entire study time of 12 years. The risk of recurrence was enhanced for th… Show more
“…Kennedy et al rightly point out that their study provides little if any evidence that modern treatments are impacting on the frequency of recurrence of depressive disorders. Their survival curves of recurrence differ very little from those in the Edinburgh (Surtees & Barkley, 1994) and NIMH (Mueller et al 1999) series that had been ascertained 15 and 10 years previously.…”
Section: No Improvement In Recurrence Rates Over 15 Years ?mentioning
confidence: 93%
“…Kennedy et al (2003) identify four studies published in the past 15 years that embody many of these advances and allow for exploration of possible temporal trends. These include the London, Sydney and NIMH investigations outlined above, and a report from Edinburgh (Surtees & Barkley, 1994), which followed a predominantly in-patient cohort of depressed patients for 12 years.…”
Well conducted investigations into the long-term outcome of depressive disorders are rare. This issue of Psychological Medicine publishes two important papers reporting on different cohorts of depressed patients, one series from Japan (Kanai et al. 2003) and the other from Cambridge UK (Kennedy et al. 2003). Both were ascertained in the early 1990s and have been followed for 5–6 and 8–10 years respectively. Each study demonstrates methodological advances. Both invite comparison with previous reports of the long-term outcome of depression whose follow-up periods span the last 40 years. Is the outcome of depressive disorders at last improving in the era of modern treatments? Is this merely an artefact of better research methods, or does it also reflect therapeutic advances? If there has been very little improvement in some aspects of outcome, what lessons can we learn for future research and practice development?
“…Kennedy et al rightly point out that their study provides little if any evidence that modern treatments are impacting on the frequency of recurrence of depressive disorders. Their survival curves of recurrence differ very little from those in the Edinburgh (Surtees & Barkley, 1994) and NIMH (Mueller et al 1999) series that had been ascertained 15 and 10 years previously.…”
Section: No Improvement In Recurrence Rates Over 15 Years ?mentioning
confidence: 93%
“…Kennedy et al (2003) identify four studies published in the past 15 years that embody many of these advances and allow for exploration of possible temporal trends. These include the London, Sydney and NIMH investigations outlined above, and a report from Edinburgh (Surtees & Barkley, 1994), which followed a predominantly in-patient cohort of depressed patients for 12 years.…”
Well conducted investigations into the long-term outcome of depressive disorders are rare. This issue of Psychological Medicine publishes two important papers reporting on different cohorts of depressed patients, one series from Japan (Kanai et al. 2003) and the other from Cambridge UK (Kennedy et al. 2003). Both were ascertained in the early 1990s and have been followed for 5–6 and 8–10 years respectively. Each study demonstrates methodological advances. Both invite comparison with previous reports of the long-term outcome of depression whose follow-up periods span the last 40 years. Is the outcome of depressive disorders at last improving in the era of modern treatments? Is this merely an artefact of better research methods, or does it also reflect therapeutic advances? If there has been very little improvement in some aspects of outcome, what lessons can we learn for future research and practice development?
“…(12,13). Although much of this excess is attributable to non-medical causes of death such as injury and suicide, it is becoming clear that MDD also increases the risk of death from common chronic diseases such as cardiovascular disease (CVD) (14).…”
“…The natural course of depression is often prolonged, relapsing or recurrent (Surtees & Barkley, 1994). Although patients are significantly helped by any well informed and responsive professional intervention, including really good clinical management, the resistant core of any significant psychopathology is a fact of life.…”
Section: Advances In Psychiatric Treatmentmentioning
confidence: 99%
“…As these figures suggest, depression can be a circumscribed, selflimiting condition for some people, but a significant proportion will suffer a pattern of remission and relapse (Surtees & Barkley, 1994), and will show a tendency for a deteriorating outlook as time goes by (Paykel, 1994) (Box 1). Yet, the majority of RCTs of psychological therapy and pharmacotherapy involve shortterm treatments of acutephase depression, with nonexistent or brief followups.…”
Section: Preliminaries For a Frame Of Referencementioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.